Cisco
CSCO
Netflix
NFLX
Adobe
ADBE
4
Microsoft
MSFT
5
Broadcom
AVGO
US Stock MarketDetailed Quotes
DMAC DiaMedica Therapeutics
- 4.070
- +0.070+1.75%
Close May 15 16:00 ET
- 4.070
- 0.0000.00%
Post 16:05 ET
174.54MMarket Cap-6.36P/E (TTM)
4.225High3.885Low115.89KVolume3.990Open4.000Pre Close473.78KTurnover0.48%Turnover RatioLossP/E (Static)42.88MShares6.81852wk High5.14P/B98.36MFloat Cap2.14052wk Low--Dividend TTM24.17MShs Float10.880Historical High--Div YieldTTM8.50%Amplitude1.120Historical Low4.088Avg Price1Lot Size
About DiaMedica Therapeutics Company
DiaMedica Therapeutics, Inc. operates as a clinical stage biopharmaceutical company, which engages in the development of novel recombinant proteins. It develops the DM199 product candidate, which focuses on acute ischemic stroke (AIS) and chronic kidney disease (CKD). The company was founded by Wayne Lautt on January 21, 2000 and is headquartered in Minneapolis, MN.
Company Profile
SymbolDMAC
Company NameDiaMedica Therapeutics
Listing DateDec 7, 2018
Issue Price4.00
Founded2000
CEOMr. Rick Pauls
MarketNASDAQ
Employees28
Fiscal Year Ends12-31
Address301 Carlson Parkway,Suite 210
CityMinneapolis
ProvinceMinnesota
CountryUnited States of America
Zip Code55305
Phone1-763-496-5454
Websitehttp://www.diamedica.com
Company Executives
- Name
- Position
- Salary
- Rick Pauls
- Director, President and Chief Executive Officer
- 1.55M
- Lorianne Masuoka, M.D.
- Chief Medical Officer
- --
- Scott Kellen
- Chief Financial Officer, Principal Accounting Officer and Secretary
- 813.96K
- David J. Wambeke
- Chief Business Officer
- --
- James T. Parsons
- Chairman of the Board
- 119.85K
- Daniel J. O’Connor, J.D.
- Director
- --
- Richard D. Pilnik
- Independent Director
- 161.41K
- Tanya N. Lewis, M.S.
- Independent Director
- 106.97K
- Charles P. Semba, M.D.
- Independent Director
- 114.75K
- Dr. Richard E. Kuntz, M.D.,M.Sc.
- Independent Director
- 105.15K
- Dr. Michael Giuffre, M.D.
- Independent Director
- 115.98K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀